Evaluation of medicinal use of Tukhm-e-Suddab (seeds of Ruta graveolens) in management of Atherosclerosis
Phase 2
Completed
- Conditions
- Health Condition 1: null- Apparently healthy, but diagnosed as atherosclerosis according to the periscope scale.
- Registration Number
- CTRI/2018/03/012714
- Lead Sponsor
- atioinal Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
(a) Patient of either sex (b) Patients of age 25-60 years (c) Peripheral arterial diseases (PAD) (d) ABI <= 0.9 or (e) ASI > 80.
Exclusion Criteria
(a) Uncontrolled diabetes (HbA1c > 9) and hypertension (160 110 mm of Hg) (b) Severe systemic diseases like chronic kidney disease or congestive heart failure etc. (c) Pregnant and lactating women (d) Patient who fails to follow up or give consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the efficacy of Unani single drug Tukhme Suddab (seeds of Ruta graveolens) by assessing changes in Periscope (Ankle Brachial Index and Arterial Stiffness Index).Timepoint: Ankle Brachial Index (ABI): Oth, 30th,60th and 90th day. <br/ ><br>Arterial Stiffness Index (ASI): Oth, 30th,60th and 90th day.
- Secondary Outcome Measures
Name Time Method ipid profile includes cholesterol, triglyceride, HDL, and LDLTimepoint: Lipid profile: Oth, 30th,60th and 90th day.